SI0797997T1 - Use of peptidic bradykinin antagonists for the preparation of medicaments - Google Patents

Use of peptidic bradykinin antagonists for the preparation of medicaments

Info

Publication number
SI0797997T1
SI0797997T1 SI9730710T SI9730710T SI0797997T1 SI 0797997 T1 SI0797997 T1 SI 0797997T1 SI 9730710 T SI9730710 T SI 9730710T SI 9730710 T SI9730710 T SI 9730710T SI 0797997 T1 SI0797997 T1 SI 0797997T1
Authority
SI
Slovenia
Prior art keywords
preparation
medicaments
bradykinin antagonists
peptidic bradykinin
liver
Prior art date
Application number
SI9730710T
Other languages
English (en)
Slovenian (sl)
Inventor
Gerhard Dr. Breipohl
Stephan Dr. Henke
Jochen Dr. Knolle
Klausm Dr. Wirth
Max Dr. Hropot
Martin Dr. Bickel
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of SI0797997T1 publication Critical patent/SI0797997T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9730710T 1996-03-27 1997-03-14 Use of peptidic bradykinin antagonists for the preparation of medicaments SI0797997T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
EP97104345A EP0797997B1 (de) 1996-03-27 1997-03-14 Verwendung von peptidischen Bradykinin-Antagonisten zur Herstellung von Arzneimitteln

Publications (1)

Publication Number Publication Date
SI0797997T1 true SI0797997T1 (en) 2005-10-31

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730710T SI0797997T1 (en) 1996-03-27 1997-03-14 Use of peptidic bradykinin antagonists for the preparation of medicaments

Country Status (24)

Country Link
US (1) US5863901A (id)
EP (1) EP0797997B1 (id)
JP (1) JP4185169B2 (id)
KR (1) KR100453394B1 (id)
CN (1) CN1164421A (id)
AT (1) ATE297749T1 (id)
AU (1) AU1651697A (id)
BR (1) BR9701455A (id)
CA (1) CA2200040A1 (id)
CZ (1) CZ90797A3 (id)
DE (2) DE19612067A1 (id)
DK (1) DK0797997T3 (id)
ES (1) ES2242973T3 (id)
HR (1) HRP970171A2 (id)
HU (1) HUP9700642A3 (id)
ID (1) ID16413A (id)
IL (1) IL120521A0 (id)
NO (1) NO971453L (id)
PL (1) PL319193A1 (id)
PT (1) PT797997E (id)
SI (1) SI0797997T1 (id)
SK (1) SK39297A3 (id)
TR (1) TR199700228A2 (id)
ZA (1) ZA972599B (id)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
CA2728766A1 (en) * 2008-06-20 2009-12-23 Kinemed, Inc. Compositions for the treatment of fibrotic diseases or conditions
TWI768156B (zh) 2017-11-24 2022-06-21 荷蘭商帕法瑞斯荷蘭有限公司 新穎緩激肽ｂ２受體拮抗劑及其用途
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
AU3428089A (en) * 1988-03-25 1989-10-16 The Administrators Of The Tulane Eductional Fund Therapeutic peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
EP0586613A4 (en) * 1991-04-01 1994-08-24 Cortech Inc Bradykinin antagonists
ATE169823T1 (de) * 1991-04-19 1998-09-15 Scios Nova Inc Bradykinin typische peptide
CA2106762C (en) * 1991-04-19 2000-10-10 Donald J. Kyle Bradykinin antagonist peptides
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (id) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994006453A1 (en) * 1992-09-11 1994-03-31 Stewart John M Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
ES2148347T3 (es) * 1993-09-09 2000-10-16 Scios Inc Antagonistas del receptor de la bradiquinina pseudo y no peptidica.
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
DE69533704D1 (de) * 1994-03-09 2004-12-02 Cortech Inc Bradykinin-antagonist peptide mit n-substituierten glycinen

Also Published As

Publication number Publication date
JP4185169B2 (ja) 2008-11-26
NO971453D0 (no) 1997-03-26
HU9700642D0 (en) 1997-05-28
KR970064622A (ko) 1997-10-13
IL120521A0 (en) 1997-07-13
ES2242973T3 (es) 2005-11-16
NO971453L (no) 1997-09-29
HUP9700642A3 (en) 1998-03-02
CA2200040A1 (en) 1997-09-27
EP0797997A3 (de) 2000-05-31
ZA972599B (en) 1997-09-29
DE19612067A1 (de) 1997-10-02
HRP970171A2 (en) 1998-04-30
BR9701455A (pt) 1998-08-18
CZ90797A3 (en) 1997-10-15
ATE297749T1 (de) 2005-07-15
DE59712344D1 (de) 2005-07-21
TR199700228A2 (xx) 1997-10-21
CN1164421A (zh) 1997-11-12
KR100453394B1 (ko) 2004-12-30
US5863901A (en) 1999-01-26
DK0797997T3 (da) 2005-10-17
ID16413A (id) 1997-09-25
SK39297A3 (en) 1997-10-08
PT797997E (pt) 2005-09-30
HUP9700642A2 (hu) 1998-01-28
AU1651697A (en) 1997-10-02
MX9702292A (es) 1997-09-30
EP0797997A2 (de) 1997-10-01
EP0797997B1 (de) 2005-06-15
JPH1017491A (ja) 1998-01-20
PL319193A1 (en) 1997-09-29

Similar Documents

Publication Publication Date Title
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
HU9701059D0 (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
TW250435B (id)
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
WO1995031985A3 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ZA963826B (en) A method of treatment of mania and bipolar disorder
SI0797997T1 (en) Use of peptidic bradykinin antagonists for the preparation of medicaments
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
HK1112738A1 (en) Arylsulfonamides and analogues as well as use for the treatment of neuro- degenerative disorders
MY121604A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
AU696629B2 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
HUP0103649A3 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues and their use
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
BR9712628A (pt) Derivados de 8(9)-deidroestradiol
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
EP0987022A4 (en) PREVENTIVE AND HEALING MEDICINES FOR ULCERATIVE KOLITIS AND / OR MORBUS CROHN
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
BG102009A (en) Method for the treatment of manic and two-pole disease